Dongdong Zhou

570 citations
29 papers · 389 indexed · h-index 12
Topics
Lung Cancer Treatments and Mutations (3 papers)Liver Disease Diagnosis and Treatment (3 papers)Cancer Immunotherapy and Biomarkers (3 papers)
Partner nations
ChinaUnited Kingdom

In The Last Decade

Dongdong Zhou

28 papers receiving 384 citations

Peers

Dongdong Zhou
Comparison fields: 5 of 75
  • Molecular Biology 210
  • Cancer Research 146
  • Oncology 99
  • Epidemiology 50
  • Pulmonary and Respiratory Medicine 46
Replace Yanwei Ye with:
Yanwei Ye China
Kaiyuan Hui China
Mingtian Wei China
Aundrea L. Oliver United States
Baomin Shi China
Yantao Cai China
Yajie Zhao China
Kazuki Moro Japan
Dongdong Zhou relative to Yanwei Ye China Yanwei Ye's profile →
Citations per field
00.5×8.6×
Yanwei Ye · 1×
Citations per year

Countries citing papers authored by Dongdong Zhou

Since Specialization
Citations

This map shows the geographic impact of Dongdong Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongdong Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongdong Zhou more than expected).

Fields of papers citing papers by Dongdong Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongdong Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongdong Zhou. The network helps show where Dongdong Zhou may publish in the future.

Co-authorship network of co-authors of Dongdong Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Dongdong Zhou. A scholar is included among the top collaborators of Dongdong Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongdong Zhou. Dongdong Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 12
4 28
5 6
6 8
7 5
8 5
9 2
10 17
11 3
12 3
13 5
14 12
15 14
16
Protective effects of catalpol and rhein in murine experimental autoimmune encephalomyelitis via regulation of T helper (Th) 1, Th2, Th17, and regulatory T cell responses.
6
17 22
18 18
19 27
20 13

About Dongdong Zhou

Dongdong Zhou is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 29 papers that have together received 389 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Cancer Research (146 citations), Oncology (99 citations) and Molecular Biology (210 citations). Dongdong Zhou has collaborated with scholars based in China and United Kingdom. Frequent co-authors include Teng Pan, Zhendong Shi, Lixia Cao, Jingjing Liu, Shaorong Zhao, Jin Zhang, Shuyong Zhang, Yanyan Xuan, Chao Zheng and Dexian Zheng. Their work appears in journals such as Oncogene, Scientific Reports and Cancer Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026